Cai Lay Veterinary Pharmaceutical (HNX:MKV) - Stock Price, News & Analysis

MKV Stock Overview

Manufactures and supplies veterinary pharmaceutical products in Vietnam and Indochina. More details

MKV fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	4/6
Financial Health	6/6
Dividends	0/6

Rewards

Trading at 90.9% below our estimate of its fair value

Earnings grew by 15.3% over the past year

Risk Analysis

Does not have a meaningful market cap (₫46B)

Does not have meaningful revenue (₫110B)

Latest financial reports are more than 6 months old

Cai Lay Veterinary Pharmaceutical Joint Stock Company Competitors

SPM

HOSE:SPM

₫154.2b

Phong Phu Pharmaceutical

HNX:PPP

₫157.5b

Mediplantex National Pharmaceutical

HNX:MED

₫297.8b

Pharmedic Pharmaceutical Medicinal

HNX:PMC

₫984.6b

Price History & Performance

Summary of all time highs, changes and price drops for Cai Lay Veterinary Pharmaceutical
Historical stock prices
Current Share Price	₫9,200.00
52 Week High	₫11,800.00
52 Week Low	₫8,000.00
Beta	0.57
11 Month Change	-1.08%
3 Month Change	2.22%
1 Year Change	-2.13%
33 Year Change	-53.54%
5 Year Change	n/a
Change since IPO	10.68%

Recent updates

Shareholder Returns

	MKV	VN Pharmaceuticals	VN Market
7D	0%	1.5%	0.7%
1Y	-2.1%	21.7%	9.9%

Return vs Industry: MKV underperformed the VN Pharmaceuticals industry which returned 21.7% over the past year.

Return vs Market: MKV underperformed the VN Market which returned 9.9% over the past year.

Price Volatility

Is MKV's price volatile compared to industry and market?
MKV volatility
MKV Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	3.3%
Market Average Movement	3.4%
10% most volatile stocks in VN Market	6.6%
10% least volatile stocks in VN Market	1.8%

Stable Share Price: Data is not available.

Volatility Over Time: Insufficient data to determine MKV's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2002	n/a	n/a	cailayvetco.com

Cai Lay Veterinary Pharmaceutical Joint Stock Company manufactures and supplies veterinary pharmaceutical products in Vietnam and Indochina. The company offers veterinary medicine, aquatic medicine, and animal nutrition. It provides products for cattle, pig, chicken, duck, dog, cat, fish, and other species through distributors and agents.

Cai Lay Veterinary Pharmaceutical Joint Stock Company Fundamentals Summary

How do Cai Lay Veterinary Pharmaceutical's earnings and revenue compare to its market cap?
MKV fundamental statistics
Market cap	₫46.00b
Earnings (TTM)	₫6.89b
Revenue (TTM)	₫109.52b

6.7x

P/E Ratio

0.4x

P/S Ratio

Is MKV overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MKV income statement (TTM)
Revenue	₫109.52b
Cost of Revenue	₫77.10b
Gross Profit	₫32.42b
Other Expenses	₫25.53b
Earnings	₫6.89b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	1.38k
Gross Margin	29.61%
Net Profit Margin	6.29%
Debt/Equity Ratio	0%

How did MKV perform over the long term?

See historical performance and comparison

Cai Lay Veterinary Pharmaceutical HNX:MKV Stock Report